Hepion Pharmaceuticals In... (HEPA)
NASDAQ: HEPA
· Real-Time Price · USD
0.07
0.01 (22.59%)
At close: Jun 09, 2025, 3:45 PM
Hepion Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -1.55M | -4.87M | -3.93M | -2.85M | -11.06M | -10.53M | -14.08M | -13.26M | -6.81M | -8.55M | -19.91M | -6.93M | -9.73M | -9.27M | -7.67M | -6.06M |
Depreciation & Amortization | n/a | n/a | n/a | 30.76K | 12.27K | 18.5K | 18.33K | 18.04K | 18.48K | 17.73K | 18.53K | 22.73K | 23.41K | 23.11K | 21.41K | 18.14K |
Stock-Based Compensation | 28.63K | 28.63K | 28.63K | 705.77K | 150.32K | 318.91K | -1.06M | 1.93M | 231.94K | 616.84K | 162.51K | 1.54M | 847.52K | 1.47M | 1.39M | 957.87K |
Other Working Capital | 44.34K | 2.24M | -1.03M | 361.37K | -815.28K | 477.97K | 523.93K | 2.48M | 1.45M | 1.19M | 2.79M | -4.44M | 576.15K | -3.26M | -1.42M | -389.47K |
Other Non-Cash Items | 321.62K | 407.69K | -4.53M | 3.9M | -260K | -140K | -88.43K | 48.43K | -80K | 80K | -90K | -324.99K | 730.91K | 749.99K | 810.01K | 30K |
Deferred Income Tax | n/a | n/a | n/a | n/a | 4.1M | n/a | n/a | n/a | n/a | n/a | 1.87M | n/a | 10.91K | n/a | n/a | n/a |
Change in Working Capital | 44.34K | 1.91M | -2.5M | -2.14M | -1.94M | -906.71K | 2.77M | 3.05M | 1.84M | -4.7M | 10.45M | -4.44M | 748.87K | -4.3M | 271.1K | -2.29M |
Operating Cash Flow | -1.15M | -2.52M | -10.93M | -3.62M | -9M | -11.24M | -12.44M | -8.21M | -4.8M | -12.53M | -7.5M | -10.13M | -7.38M | -11.32M | -5.17M | -7.35M |
Capital Expenditures | n/a | n/a | n/a | n/a | -348 | 2.58K | -16.54K | n/a | -16.34K | n/a | n/a | n/a | n/a | -36.49K | -11.81K | -82.11K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.27K | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -600K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.27 | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | -600K | n/a | n/a | -348 | 2.58K | -16.54K | n/a | -16.34K | n/a | 2.27K | n/a | n/a | -36.49K | -11.81K | -82.11K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | -1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 2.5M | n/a | 1.85M | 4.49M | n/a | n/a | n/a | -3.14M | n/a | n/a | -2M | n/a | n/a | -176.59K | n/a |
Financial Cash Flow | n/a | 2.5M | n/a | 1.85M | 4.49M | n/a | n/a | n/a | -3.14M | n/a | n/a | -2M | n/a | n/a | -176.59K | 82.15M |
Net Cash Flow | -1.09M | -617.94K | -10.99M | -1.68M | -4.5M | -11.24M | -12.47M | -8.2M | -7.96M | -12.56M | -7.52M | -12.13M | -7.38M | -11.36M | -5.36M | 74.72M |
Free Cash Flow | -1.15M | -2.52M | -10.93M | -3.62M | -9M | -11.23M | -12.45M | -8.21M | -4.81M | -12.53M | -7.5M | -10.13M | -7.38M | -11.36M | -5.18M | -7.43M |